USE OF DIRECT ORAL ANTICOAGULANTS IN DIALYSIS PATIENTS WITH ATRIAL FIBRILLATION IN THE UNITED STATES

MLA

Brahmajee K. Nallamothu, et al. “Use of Direct Oral Anticoagulants in Dialysis Patients with Atrial Fibrillation in the United States.” Journal of the American College of Cardiology, vol. 71, Mar. 2018, p. A512. EBSCOhost, https://doi.org/10.1016/s0735-1097(18)31053-2.

APA

Brahmajee K. Nallamothu, Konstantinos C. Siontis, Nilay Shah, Austin G. Stack, Ashley Eckard, Nicole M. Bhave, Peter A. Noseworthy, Rajiv Saran, Rajesh Balkrishnan, Xiaoxi Yao, & Kevin He. (2018). Use of Direct Oral Anticoagulants in Dialysis Patients with Atrial Fibrillation in the United States. Journal of the American College of Cardiology, 71, A512. https://doi.org/10.1016/s0735-1097(18)31053-2

Chicago

Brahmajee K. Nallamothu, Konstantinos C. Siontis, Nilay Shah, Austin G. Stack, Ashley Eckard, Nicole M. Bhave, Peter A. Noseworthy, et al. 2018. “Use of Direct Oral Anticoagulants in Dialysis Patients with Atrial Fibrillation in the United States.” Journal of the American College of Cardiology 71 (March): A512. doi:10.1016/s0735-1097(18)31053-2.